|
Other DES Exposure Victims
Women Prescribed DES While Pregnant
Women who were prescribed DES while pregnant are at a modestly
increased risk for developing breast cancer. Studies have
consistently reported an increased risk of approximately 30%
for women prescribed DES while pregnant. That means when considering
breast cancer risks across a lifetime, one in six women prescribed
DES during pregnancy will get breast cancer. In comparison,
only one in eight unexposed women will get breast cancer across
their lifetime.
Third Generation DES Exposure
Third-generation children (the offspring of DES Daughters
and DES Sons) are just beginning to reach the age when relevant
health problems (such as reproductive tract problems), can
be studied.
A study of the health risks for the granddaughters of women
prescribed DES while pregnant, or third-generation daughters,
was published in 2002. The researchers compared findings of
pelvic examinations of 28 DES Granddaughters with findings
noted in their mothers (DES Daughters). Even though abnormalities
were present in more than 60% of DES Daughters, no abnormalities
were found in the DES Granddaughters (Kaufman, 2002).
DES Grandsons are being studied at the Netherlands Cancer
Institute. Early research reported that hypospadias, misplaced
opening of the penis, occurred 20 times more frequently among
sons of DES Daughters (Klip, 2002).
* source - Center for Disease Control and
Prevention
DES Exposure Victims
|
